Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Increase in multiple sclerosis activity after assisted reproduction technology.
The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.
MRI outcomes in the diagnosis and disease course of multiple sclerosis.
Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis.
The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19: Reliability, Validity, and Factor Structure of the Persian Version.
Poor responses to interferon-Beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.
Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis.
Pain in neuromyelitis optica-prevalence, pathogenesis and therapy.
Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid.
MicroRNA-23a promotes myelination in the central nervous system.
[Differntial diagnosis of neuromyelitis optica].
Undiagnosed neurological disease as a potential cause of male lower urinary tract symptoms.
The ideal healthcare: priorities of people with chronic conditions and their carers.
Four Hours is Enough for Lactation Interruption After High-Dose Methylprednisolone Treatment in Multiple Sclerosis Mothers by Measuring Milk Cortisol Levels.
Acute hypoxic-ischemia in cardiac arrest encephalopathy causes only minimal demyelination.
Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.
[The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.
Social network diversity and white matter microstructural integrity in humans.
Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment.
[Use of vitamins for correction of the functional state of cytochrome P450 systems at experimental allergic encephalomyelitis].
[Factors associated to the work situation of patients with multiple sclerosis].
A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.
Pages
« first
‹ previous
…
593
594
595
596
597
598
599
600
601
…
next ›
last »